Veterinary Medicine Market Size, Hospital Procurement Trends, Manufacturing Capacity, Sales Performance, Regulatory Approvals, Patient Outcomes, Competitive Landscape, and Forecast

Revenue, 2025

USD 56.68 Bn

Forecast Year, 2035

USD 115.15 Bn

CAGR, 2026 - 2035

7.35%

Report Coverage

Global

What is the Veterinary Medicine Market Size?

The global veterinary medicine market size was valued at USD 56.68 billion in 2025 and is anticipated to reach around USD 115.15 billion by 2035, expanding at a CAGR of 7.35% from 2026 to 2035. Rising pet ownership, livestock diseases, and increasing demand for animal healthcare drive the veterinary medicine market.

Animals are susceptible to various illnesses caused by parasites, bacteria, fungi, and viruses, just like people. Farm animals and domestic pets suffer from fewer diseases thanks to veterinary care. Growing zoonotic and chronic animal diseases have a significant impact on human interests. Extending the lifespan of pets by constructing healthcare facilities and requiring better feeding. Chronic diseases are on the rise as a result of the growing pet population.

Veterinary Medicine Market Key Takeaways

• By Region, North America accounted for the largest revenue share of the veterinary medicine market in 2025.
• By Region, Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.
• By animal type, the production segment held a dominant position in the market in 2025.
• By animal type, the companion segment is expected to grow at the fastest CAGR market between 2026 and 2035.
• By product, the pharmaceuticals segment accounted for a considerable revenue market in 2025.
• By product, the biologics segment is expected to grow at the highest CAGR market during the study period.
• By mode of delivery, the parenteral segment led the global market in 2025.
• By mode of delivery, the oral segment is expected to expand rapidly in the market with a CAGR in the coming years.
• By end-user, the veterinary hospitals & clinics segment dominated the global market in 2025.
• By end-user, the reference laboratories segment is expected to witness the fastest growth in the market with a CAGR over the forecast period.

Targeted Biologic Innovations Reshaping the Veterinary Medicine Market

Veterinary medicine includes therapeutic products, products based on biologic products, vaccines, medicines, and products that prevent and treat ailments in animals. This is being driven by rising expenditures on animal health care. Innovation is being catalysed by innovations in biologics, diagnostics, and prevention in veterinary medicine. In addition, awareness regarding animal welfare and food safety issues is gaining momentum, helping the market.

Key AI Integration in the Veterinary Medicine Market

The veterinary industry is transforming with the introduction of AI. Machine learning works well to detect diseases at earlier stages from clinical data, images, and health data. Imaging technologies can be enhanced using AI for more accurate diagnostics and clinical judgment. AI can be used for personalized care and continuous animal ‘management'. It's improving efficiency, accuracy, and outcomes in veterinary care

Veterinary Medicine Market Growth Factors

The primary driver of this market is the increase in the cases of zoonotic as well as chronic illnesses cases. The number of livestock in the world has been rapidly increasing during the last few decades. According to the USDA, there were approximately 103 million cattle and 32.05 million beef cows in the country as of July 2020, and this number is expected to rise sharply over the following few years.

Additionally, it is anticipated that shortly, there will be a greater need for veterinary drugs and animal vaccinations due to increased R&D and procedural developments, the rate of pet adoption, rising meat consumption, and required immunization.

• An increasing number of pet ownership
• Increasing R&D and procedural advancements
• Upsurge in the number of zoonotic & chronic diseases

Market Scope

Market Dynamics

Drivers

The growing number of pet owners

The American Pet Products Association reports that the total amount spent on pets in the United States climbed to USD 103.6 billion in 2020 from USD 97.1 billion in 2019 and is predicted to reach USD 109.6 billion or more by 2022. A pet was also present in roughly 67% of American households, which in 2020 will equate to nearly 84.9 million residences. Additionally, the veterinary business is anticipated to benefit financially from R&D efforts that result in the creation of new products.

Increasing demand for pet insurance policies

Market expansion is anticipated to be fuelled by the rising adoption of pet health insurance to pay for veterinary services in developed nations. The pet health insurance market is thriving in Canada, the United Kingdom, and Sweden. In China, there has been a rapid rise in the use of pet health insurance. Two crucial factors that have contributed to the development of pet healthcare insurance are the growing popularity of pets and the growing awareness and understanding of pet health.

Government Intervension: The livestock sector is a major GDP contributor in several developing economies. Hence, governments are increasingly focusing on adoption of improved medication & vaccination facilities for a healthy livestock population. With the rising concern over animal health, the profitability index of vaccine producers is reducing. Government efforts such as bulk purchase of vaccines for assuring greater food quality and a healthy animal population are affecting distribution channels, thereby increasing the dependency of producers on government organizations. For instance, the Indian government is involved in the purchase & distribution of vaccines for foot and mouth disease in cattle as it is a major concern in the country. This is impeding the profit margins of manufacturers in India.

Rise in Livestock Population and Increasing Pet Ownership Rates

The global livestock population has been experiencing rapid growth over the past few decades. According to a USDA report, there were around 94.4 million cattle & calves in the U.S., as of 2017. In developing economies, the demand for livestock products is increasing. According to the 19th Animal Census Report, India was home to a livestock population of about 512 million. Growing concern about food security and increasing animal husbandry occupations are boosting the demand for veterinary pharmaceuticals & vaccines for livestock. Increasing demand for animal products has intensified livestock production worldwide. Factors such as changes in food preferences owing to changing lifestyle habits and population growth are further boosting the demand for livestock products.

Increase in the number of pet owners is driving the need for better treatment options for companion animals. According to The Humane Society of the United States reports, around 60.2 million U.S. households had at least 1 dog and around 47.1 million households had 1 cat, as of 2017. According to The American Pet Products Association report of 2018, overall spending in the U.S. pet industry increased by 4.1% from 2016 to 2017. Moreover, veterinary care spending increased by 7%, from USD 15.95 billion in 2016 to USD 17.07 billion in 2017. The increasing demand for vaccination and drugs is likely to propel the market over the forecast period.

Short Product Exclusivity Period

Demand for innovative animal health vaccine solutions is increasing, owing to the growth in disease outbreaks and commercialization of animal products. The exclusivity period of veterinary vaccines and other pharmaceuticals related to animal health is about 3 to 5 years. In addition, stringent regulatory policies and complex approval procedures are restricting the launch of new products, limiting the overall profitability of pharmaceutical & vaccine manufacturers.

Increasing Influx of Counterfeit Drugs

An influx of substandard and counterfeit drugs in the treatment of a wide range of diseases affecting animals is one of the major factors expected to restrain the market for animal health market over the forecast period. Counterfeit medicines are available at low costs and developed without adequate clinical testing, increasing the risk of adverse effects in animals. This issue is more common in emerging economies and is expected to impede the market to a significant extent over the coming years. According to the European Commission, approximately 20% to 30% of counterfeit drugs were found in India, Africa, & South America and nearly 10% to 20% of counterfeit drugs were found in European countries.

In addition, scarce and erratic supply of pharmaceuticals, unaffordable pricing, and availability of unregulated therapeutics are anticipated to propel the production of counterfeit drugs. The growing use of e-commerce platforms for veterinary healthcare sales and distribution is further widening the scope for the sale of counterfeit drugs. These factors cumulatively exert a negative impact on the market.

Challenges

• High cost associated with veterinary medicines - The market for veterinary pharmaceuticals will, however, experience a slower growth rate due to the high cost of these products. The growth of the veterinary medicine industry will also be hampered by the rising prevalence of infections and the growing number of fake medications. The COVID-19 outbreak and lack of knowledge, along with the advent of unfavorable conditions, will present additional challenges for the industry during the aforementioned projected period.

Segment Insights

Animal Type Insights

In 2025, the production animal market segment held the top spot & accounted for more than 55.0% of worldwide revenue. Fish, swine, cattle, poultry, fish, sheep, and goats are other subcategories of the producing animal industry. The world's expanding dietary protein needs is the cause of producing animals capturing the lion's share of the market.

The widespread acceptance of such production animals is also seen to be a result of rising spending on animal healthcare, particularly in industrialized nations. The entire output of eggs, broilers, and turkey, as well as the number of chicken sales, were estimated by the USDA's National Agricultural Statistics Service to be worth USD 35.5 billion previously.

Due to the rise in chronic conditions, the companion animal segment is expected to grow at the highest CAGR over the forecast period. According to an AVMA estimate, dog and cat owners spent over USD 95.7 billion on pets in the United States in 2019. Over the anticipated period, the aforementioned variables are anticipated to fuel market expansion.

The companion segment is expected to witness strong growth during the forecast period with a continuous rise in pet ownership, both internationally and domestically. The demand for dogs comes from a substantial number of dogs and the variety of their health concerns. Cats are also playing their part in the market's growth as they are seen investing in preventive and therapeutic health care for their felines. There is an increasing demand for special medicines, vaccines, and disease-management products from horses.

Product Insights

The market is divided into pharmaceuticals, medicated feed additives, and biologics, pharmaceuticals based on product. The vaccines and other sections of the biologics market are divided into the subcategories of pharmaceuticals including analgesics, anti-inflammatories, parasiticides, and others.

Pharmaceuticals held a market share of more than 60% in 2024 as a result of the rise in zoonotic diseases, brucellosis, and food-borne disorders. The biologics section is predicted to expand at the fastest rate over the forecast period because more livestock and companion animals are utilizing vaccines to avoid sickness.

The factor driving the demand for vaccinations as a defense against such diseases is the enormous losses the animal breeding sector has suffered as a result of epidemics in earlier years. Additionally, a sizable number of mergers and acquisitions made by important market players to broaden their vaccination product range are anticipated to significantly increase the market's growth potential.

Due to their expanding use in preserving animal health, the market for medical feed additives is also anticipated to expand significantly during the forecast years. The demand for meat and dairy is also increasing as a result of the growing world population, which also contributes to category growth.

The biologics segment is expected to grow significantly during the forecast period, owing to the rising demand for innovative preventive and therapeutic products. Vaccines are indeed the part and parcel of Veterinary Biologics as they play an integral role in the prevention of infectious diseases. DNA vaccines are becoming more and more popular due to their targeted and innovative protection against diseases.

The medicated feed additives segment is projected to grow at a notable pace driven by increasing focus on health and disease prevention in livestock. With the growth of livestock production, demand for efficient strategies for animal health management is rising. However, diseases can be controlled using the correct medicated feed additives, and the health of a herd can be enhanced.

Mode of Delivery Insights

The market is divided into parenteral, oral, and other administration routes depending on the method of administration. Other topics covered in this part include topical and targeted medication delivery. In 2025, the parenteral segment held the largest market share of around 45%. The rise can be attributed to the accessibility of the product and the prompt start of the action.

It is favored for speedier action because the therapeutic impact of parenteral medications is often realized an hour after delivery. Due to developments in the oral veterinary medication sector, such as chewable pills, the oral segment is anticipated to grow at the quickest CAGR between 2024 and 2034.

Additionally, the frequency of chronic diseases in dogs is anticipated to fuel market expansion. For instance, Merck expanded its product line when the U.S. FDA approved Bravecto monthly chews for dogs and pups in July 2020. Powder and pills are further divided into categories for the oral method of delivery. Suspension, topical application, and carrier are further administration methods.

Because it is widely used to treat animal skin infections, the topical segment is anticipated to account for the greatest market share among these. But, due to improvements made in the segment by market players, the carrier category is anticipated to develop at the quickest CAGR from 2026 to 2035.

The oral segment is expected to grow steadily during the forecast period due to the convenience of oral administration and its ease of use. Oral veterinary medicines may be given in various forms, depending on the species of animal and method of treatment. A good choice for powders is that they can be added to feed or to water if needed. Many companion animals benefit from the ease of use when it comes to dosage, including tablets.

End-User Insights

The segment of veterinary hospitals and clinics has emerged as a dominant market and generated more than 73% of revenue share in 2024. The availability of innovative therapeutics, laser diagnostics, nuclear and regenerative medicines, and specialist surgery in veterinary hospitals & clinics can be credited with the growth.

Over the course of the projection period, reference laboratories are anticipated to grow at the quickest CAGR due to their ability to evaluate numerous infections, hazardous chemicals, & chronic diseases in animal specimens.

These tests include both standard laboratory testing and unique tests. Point-of-care testing & in-house testing are also anticipated to experience substantial expansion because of their practicality, accuracy in symptomatic testing, simplicity of use, and speed of analysis. Companies' strategic moves are anticipated to support market expansion. For instance, AAD announced an investment of USD 7.0 million to develop the company's platform for swift judgments in the field of animal and human health.

The reference laboratories segment is expected to witness notable growth. These laboratories offer state-of-the-art testing for chronic, genetic, and infectious diseases in animals. The increasing complexity of diseases is starting to prompt vets to seek laboratory diagnosis. Recent advances in molecular testing and automation of the laboratory are leading to greater diagnostic possibilities.

The point-of-care testing/in-house testing segment is expected to grow steadily. These tests enable veterinarians to get results on time during clinical consultations. Faster diagnosis will be able to assist timely treatment decisions as well as better patient management. In-store science bench-top devices are becoming more accurate and user-friendly in diagnostic ability.

Regional Insights

Why Did North America Dominate the Veterinary Medicine Market?

North America dominated the global market in 2025, led by its well-established animal health, care, and welfare systems. There is a high prevalence of pet ownership and a high proportion of expenditure on companion animal healthcare in the region. Demand for veterinary medicine and veterinary vaccines also comes from good livestock production. There is a substantial existing pharmaceutical and biotechnology industry. Advanced veterinary hospitals and diagnostic equipment add to the regional demand.

What is the U.S. Veterinary Medicine Market Size?

U.S. market is anticipated to grow significantly, due to increased pet ownership and higher spending on animals' health. Pet owners are moving towards seeking “preventive” medical services, diagnostics, and specialty treatments more and more. The country also has a significant livestock industry that needs drug treatment, vaccines, and disease control. Innovative health care technologies are being embraced by advanced veterinary hospitals and diagnostic labs.

U.S. Veterinary Medicine Market size was estimated at USD 12.70 billion in 2025 and is expected to be worth around USD 26.53 billion by 2035, rising at a CAGR of 7.64% from 2026 to 2035.

The market for veterinary medicine has been dominated by North America and generated more than 27% of the revenue in 2025. The rising incidence of zoonotic infections, favorable reimbursement policies, and rising costs for companion animals are major contributors to the domination. According to the American Pet Products Association's (APPA) 2021–2022 National Pet Owners Survey, almost 70% of American households—or 90.5 million households—have pets.

The identical source claimed that for the year 2025, the cost of normal visits for dogs was USD 242, compared to USD 178 for cats. The number of Americans who own pets & livestock is rising, and with it, so is their awareness of the animals' welfare. The American Pet Products Association reports that American pet spending is also increasing, which might fuel industry expansion. Therefore, the market is anticipated to have significant expansion in the future due to growing awareness of and spending on animal health.

A Management of Canada paper on reported diseases in animals was updated in 2022 and includes some diseases that affect animals, including pets in the area. Pullorum disease, Vesicular stomatitis, equine infectious anemia, and Newcastle disease are further conditions on the long list of illnesses. All of these advancements are predicted to further fuel market expansion.

The veterinary medicine market is experiencing steady growth, and the growth is driven by increasing pet ownership as growing trend towards fostering and domesticating the animals has increased notable in the country, rising demand for animal care products like soaps, shampoos, medicines drives the growth and demand for the market and ownership, rising demand for animal protein derived form plants and natural sources also is in increasing demand which drives the growth of the market, and advancements in veterinary healthcare, emerging technologies such as regenerative medicine, digital diagnostics, and personalized therapeutic play a pivotal role in the market. This helps in the growth and expansion of the veterinary medicine market.

Asia Pacific is Undergoing the Fastest Growth in the Veterinary Medicine Market

Asia Pacific is expected to grow at the fastest rate in the market as its livestock production and the growing number of companion animals are expected to drive market growth. Increasing recognition of animal health is promoting increased adoption of veterinary medicines and vaccines. The rising consumption of animal-derived food products is raising awareness of livestock disease prevention. Veterinary infrastructure development is increasing veterinary care access.

China Market Trends

China's veterinary medicine market is anticipated to grow significantly, due to the vast number of animals and increasing animal health concerns. Poultry and Swine industries in the country generate high requirements for the development of disease prevention and treatment products. Growth of companion animal healthcare is also being helped by a rise in pet ownership. Veterinary medicine is encouraged by the initiatives adopted by the government in animal diseases and food safety high standards.

Advancements in the Veterinary Medicine Market in Europe

Europe is expected to witness significant market growth throughout the forecast period and will become more focused on animal welfare and preventative healthcare. The area has veterinary health care systems and advanced diagnostic and analysis abilities. Ownership of companion animals continues to boost demand for medication, vaccines, and specific treatments. Livestock producers are also working to prevent disease and responsibly manage animal health.

Germany Market Trends

Germany market is anticipated to grow significantly due to the excellent veterinary infrastructure and that animal health is on the rise. There is a strong companion animal health-care industry and strong ownership of animals in the country. It is also a source of demand for preventive medicines and products for disease control in its livestock sector. Veterinary medicines are also being given a demand boost from companion animal ownership, which has also increased in several countries.

Key Trends in the Veterinary Medicine Market in Latin America

Latin America is expected to witness significant growth in the market due to upcoming trends in the region such as the growth of livestock production and the demand for animal health care products. Working disease prevention and treatment solutions are needed in the region due to large local cattle, poultry, and swine industries. With the rising exports of animal products, livestock health and food safety come into the spotlight.

Brazil Market Trends

Brazil veterinary medicine market is anticipated to grow significantly, due to its considerable animal population and robust agriculture industry. There is high demand for vaccines, anti-parasitic drugs, and other production inputs required by the country's beef industry. As the number of pets continues to rise, so does the demand for medicines and other prevention and wellness services for pets.

Growth of the Middle East and Africa in the Veterinary Medicine Market

The Middle East and Africa region is expected to witness significant growth in the market as animal health awareness and rising livestock production will be key factors. Domestic livestock production is significant for food security and rural incomes within the region. The demand for medicines and vaccines for infectious animal diseases is growing since the diseases have been prevalent. Improvements in veterinary infrastructure are gradually improving access to modern healthcare products.

Saudi Arabia Market Trends

Saudi Arabia market is anticipated to grow significantly, as they are investing in Livestock health and veterinary improvement infrastructure. The fact that there is increased demand for food products of animal origin is driving stronger efforts towards disease prevention. With the rise in pets in the city has gone an increased demand for companion animal health care. Opportunities for veterinary medicine providers are available due to support for the provision of food security and livestock development by the government.

Government Initiatives

United States

The National Animal Disease Preparedness and Response Program (NADPRP) bolsters animal disease preparedness and response efforts. A new animal and veterinary medicines and animal health scholarship program at the FDA Animal and Veterinary Innovation Centers.

India

The Livestock Health and Disease Control Programme (LHDCP) supports the vaccination programme, disease monitoring and veterinary infrastructure. The National Animal Disease Control Programme (NADCP) has particular emphasis on the control of brucellosis and foot and mouth disease.

China

The National Animal Disease Surveillance Program boosts monitoring and early detection of animal diseases in China. Compulsory Animal Disease Vaccination Program assists with vaccination against major priority diseases.

Germany

The EU Animal Health Law looks at measures for preventing and controlling transmissible animal diseases. EU animal disease surveillance and control programmes ensure early detection and effective and coordinated disease management at the EU level.

Value Chain Analysis-Veterinary Medicine Market

• R&D: The focus is on the development of new, novel drugs, biologics, vaccines, and diagnostics, and the solution of emerging animal diseases, treatment needs, safety, and efficacy.
  • Key Players: Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco, Virbac, Ceva Santé Animale
• Clinical Trials and Regulatory Approvals: To conduct clinical trials on animals and obtain regulatory approval for veterinary products, the product is tested for safety, effectiveness, and quality.
  • Key Players: Merck Animal Health, Elanco, IDEXX Laboratories, Charles River Laboratories
• Distribution to Hospitals, Pharmacies: Authorised veterinary products are supplied in veterinary hospitals, veterinary clinics, veterinary pharmacies, specialised retailers and wholesalers, ensuring a constant flow in the animal health markets.
  • Key Players: MWI Animal Health, Patterson Veterinary, Zoetis, Elanco, Merck Animal Health

Competitive Landscape

The veterinary medicine market is competitive, with several key players supplying veterinary medicines, vaccines, biologicals, animal healthcare products and laboratory diagnostic products. Key players are Ceva Santé Animale, Vetoquinol S.A., Zoetis, Biogenesis Bago and Neogen Corp. These businesses are focused on geographical expansion, strategic initiatives, R&D, acquisitions and product innovation initiatives, to support their market presence.

Investment in new technologies like advanced biologic pharmaceuticals, vaccines, diagnostics, and digital veterinary technologies is a growing priority to give companies a competitive advantage. Market participants are increasingly expanding their presence with vet clinics, livestock producers, distributors, and government entities.

Veterinary Medicine Market Companies

• Ceva Sante Animale
• Vetoquinol S.A.
• Zoetis
• Biogenesis Bago
• Neogen Corp.
• Hester Biosciences
• Phibro Animal Health
• Ceva Sante Animale
• Vetoquinol S.A.
• Dechra Pharmaceuticals PLC

Recent Development

• In May 2025, Royal Canin launched a new range of supplements and probiotics for pets, alongside the introduction of National Pet Wellness Day on May 8. The initiative aims to highlight the importance of personalized pet health care.
• In April 2025, Cordyceps Sunshine Biotech Holdings (C.S Group) unveiled its Antcin A-based veterinary drug initiative for Taiwan and China. The announcement was made during a major conference on the applications of Taiwanofungus camphoratus in the pet industry.
• In March 2025, Privo Technologies Inc. launched BeneVet Oncology, a new subsidiary focused on veterinary health. The company aims to use its innovative drug delivery systems to treat cancer and other conditions in companion animals.
• In April 2025, Transcend Biologics introduced TropoVet™ PRP, a regenerative medicine product designed for the veterinary market. The company, founded from Eclipse MedCorp, brings decades of experience in medical devices to support advancements in pet health care.

Segments Covered in the Report

By Animal Type

• Production
  • Poultry
  • Swine
  • Cattle
  • Sheep & Goats
  • Fish
• Companion
  • Dogs
  • Cats
  • Horses
  • Others

By Product

• Biologics
  • Vaccine
  • Live Attenuated Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Inactivated Vaccines
  • Others
• Others
• Pharmaceuticals
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory
  • Analgesics
  • Others
• Medicated Feed Additives

By Mode of Delivery

• Oral
  • Powder
  • Tablets
• Parenteral
  • Suspension
  • Topical
  • Carrier
• Other

By End-User

• Reference Laboratories
• Point-of-care Testing/In-house Testing
• Veterinary Hospitals & Clinics
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa